American Injectables, a Florida-based contract development and manufacturing organisation (CDMO) specialising in sterile injectables, announced on Thursday that it has received US Food and Drug Administration (FDA) approval, ensuring that its injectables meet the stringent regulatory standards needed for patient safety and efficacy.
FDA approval positions American Injectables as a trusted partner for pharmaceutical companies seeking scalable and compliant sterile injectable solutions, the company said.
"Receiving FDA approval not only validates the strength of our manufacturing processes and our team's dedication to quality but also reinforces our commitment to our clients," said Travis Allen, interim CEO of American Injectables. "It enables them to bring life-saving therapies to market faster and with greater confidence."
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval